ArticleScientific reports2026
Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical determinants of retinal age gap estimated from fundus photographs in glaucoma patients.Scientific reports · 2026Observational
- Macula- Versus Disc-Centered Fundus Photography: Performance in Age-Prediction and Disease Associations.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accelerated biological aging, as well as cardiovascular, kidney, and metabolic (CKM) diseases, contribute to shortened healthspan. We studied a deep-learning model, retinal BioAge, and multiple indicators of CKM syndrome in participants from UK Biobank and the US-based EyePACS dataset. Retinal BioAge was trained on 77,887 retinal images and then used to analyze separate retinal images from UK Biobank (10,976) and EyePACS (19,856). In both datasets, CKM biomarker profiles were significantly worse for the top vs. bottom quartiles of BioAgeGap (retinal BioAge-chronological age), including measures of blood pressure, kidney function, adiposity, and glycemia. The top BioAgeGap quartile also had a significantly higher prevalence of clinical CKM indicators, including hypertension, kidney disease, and diabetes (UK Biobank) or suboptimally controlled diabetes (EyePACS). Thus, analysis of retinal images for accelerated biological aging may provide opportunistic screening to help identify individuals who could benefit from formal CKM assessment, potentially contributing to earlier detection and management of CKM syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.